Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 153

Sort by

Sort Order Select

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease

Kimimori Kamijo, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Yoshihara, Takahiro Fukuda, Yasufumi Uehara, Yasuo Mori, Tetsuya Eto, Hikaru Kobayashi, Kentaro Serizawa, Tatsuo Ichinohe, Makoto Yoshimitsu, Junya Kanda, Yoshiko Atsuta, Shinichi Kako

Blood (2024) 144 (Supplement 1): 2166.

https://doi.org/10.1182/blood-2024-206578

Published: 2024

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Satoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, Masamitsu Yanada, Shohei Mizuno, Naoyuki Uchida, Noriko Doki, Ayumu Ito, Masatsugu Tanaka, Tetsuya Nishida, Yuta Katayama, Satoshi Yoshihara, Tetsuya Eto, Koji Kawamura, Makoto Onizuka, Takahiro Fukuda, Marie Ohbiki, Yoshiko Atsuta, Takaaki Konuma

Blood (2024) 144 (Supplement 1): 1469.

https://doi.org/10.1182/blood-2024-198750

Published: 2024

Journal Articles

Early Initiation of Calcineurin Inhibitor Induces CD8 + Transitory Exhausted-like and CD4 + Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide

Blood (2024) 144 (Supplement 1): 903.

https://doi.org/10.1182/blood-2024-197873

Published: 2024

Journal Articles

Integrating Genomic & Transcriptomic Features for Noninvasive Detection, Characterization, and Monitoring of T-Cell Lymphomas

Blood (2024) 144 (Supplement 1): 454.

https://doi.org/10.1182/blood-2024-206518

Published: 2024

Journal Articles

Frequent Loss of HLA-B*40:02 from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia

Blood (2024) 144 (Supplement 1): 1311.

https://doi.org/10.1182/blood-2024-197892

Published: 2024

Journal Articles

Kinetics of Recipients with Thrombocytopenia and Its Impact on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

Blood (2024) 144 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2024-201927

Published: 2024

Journal Articles

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Blood (2024) 144 (Supplement 1): 384.

https://doi.org/10.1182/blood-2024-203344

Published: 2024

Journal Articles

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

Blood (2024) 144 (Supplement 1): 4472.

https://doi.org/10.1182/blood-2024-206515

Published: 2024

Journal Articles

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

Shuichi Mizuta, Tomotaka Ugai, Satoshi Nishiwaki, Noriko Doki, Takahiro Fukuda, Tetsuya Nishida, Yuta Katayama, Shuichi Ota, Yuta Hasegawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Koji Kawamura, Yoshiko Atsuta, Yasuyuki Arai

Blood (2024) 144 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2024-201434

Published: 2024

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Ken Ishiyama, Jun Aoki, Noriko Doki, Tetsuya Nishida, Takahiro Fukuda, Naoyuki Uchida, Yasunori Ueda, Yasufumi Uehara, Yuta Katayama, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta

Blood (2023) 142 (Supplement 1): 4985.

https://doi.org/10.1182/blood-2023-173567

Published: 2023

Journal Articles

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Blood (2023) 142 (Supplement 1): 3609.

https://doi.org/10.1182/blood-2023-174431

Published: 2023

Journal Articles

Prevalence and Outcome of Vexas Syndrome in Unrelated Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 1354.

https://doi.org/10.1182/blood-2023-190791

Published: 2023

Journal Articles

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 899.

https://doi.org/10.1182/blood-2023-184709

Published: 2023

Journal Articles

Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide

Hajime Senjo, Daigo Hashimoto, Satomi Okada, Shimpei I Kubota, Ayumu Ito, Takashi Tanaka, Yumika Saito, Toru Miyajima, Wenyu Li, Zixuan Zhang, Shinpei Harada, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Yoshihiro Inamoto, Masaaki Murakami, Takahiro Fukuda, Takanori Teshima

Blood (2023) 142 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2023-181560

Published: 2023

Journal Articles

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo Fuji

Blood (2023) 142 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2023-173590

Published: 2023

Journal Articles

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Blood (2023) 142 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2023-173779

Published: 2023

Journal Articles

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Masashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, Akihito Shinohara, Naoyuki Uchida, Nobuyuki Takayama, Hikaru Kobayashi, Yasufumi Uehara, Jun Ishikawa, Kazuya Ishiwata, Nobuhiro Hiramoto, Hideyuki Nakazawa, Fumihiko Ishimaru, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Eisei Kondo, Shinichi Kako

Blood (2023) 142 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2023-178951

Published: 2023

Journal Articles

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Kaito Harada, Junya Kanda, Masahiro Hirayama, Fumiya Wada, Naoyuki Uchida, Hirohisa Nakamae, Masatsugu Tanaka, Makoto Onizuka, Hiroyuki Ohigashi, Nobuaki Nakano, Takahiro Fukuda, Kazuya Ishiwata, Yumiko Maruyama, Tetsuya Eto, Fumihiko Ishimaru, Yoshiko Atsuta, Hideki Nakasone, Takashi Tanaka

Blood (2023) 142 (Supplement 1): 4905.

https://doi.org/10.1182/blood-2023-184821

Published: 2023

Journal Articles

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Kotaro Miyao, Makoto Murata, Tetsuya Nishida, Yukiyasu Ozawa, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Tetsuya Eto, Toshiro Kawakita, Yasuo Mori, Satoru Takada, Hiroyuki Ohigashi, Masatsugu Tanaka, Yoshinobu Kanda, Ken-ichi Matsuoka, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Seitaro Terakura

Blood (2023) 142 (Supplement 1): 6993.

https://doi.org/10.1182/blood-2023-178592

Published: 2023

NARROW

Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Early Initiation of Calcineurin Inhibitor Induces CD8 + Transitory Exhausted-like and CD4 + Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide

Integrating Genomic & Transcriptomic Features for Noninvasive Detection, Characterization, and Monitoring of T-Cell Lymphomas

Frequent Loss of HLA-B*40:02 from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia

Kinetics of Recipients with Thrombocytopenia and Its Impact on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Trends and Outcomes of Hematopoietic Stem Cell Transplantation for Malignant Lymphoma in Japan between 2006 and 2021

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Prevalence and Outcome of Vexas Syndrome in Unrelated Hematopoietic Stem Cell Transplantation

Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy

Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only